z-logo
Premium
Hemizygous/homozygous and heterozygous JAK2 mutation detected in plasma of patients with myeloproliferative diseases: correlation with clinical behaviour
Author(s) -
Ma W.,
Kantarjian H.,
Verstovsek S.,
Jilani I.,
Gorre M.,
Giles F.,
Cortes J.,
O'Brien S.,
Keating M.,
Albitar M.
Publication year - 2006
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/j.1365-2141.2006.06174.x
Subject(s) - essential thrombocythemia , mutation , polycythemia vera , compound heterozygosity , mutant , valine , allele , point mutation , microbiology and biotechnology , myelofibrosis , gene , gene mutation , medicine , biology , genetics , bone marrow , amino acid

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom